These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 17133599

  • 1. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [Abstract] [Full Text] [Related]

  • 2. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 4. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Kaplan C, Clémenceau S, Castellano F, Levy M.
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [Abstract] [Full Text] [Related]

  • 5. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W, Gryga K, Milewski M, Podolec M, Kostkiewicz M, Podolec P, Musial J.
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR, Wang GS, Sharp GC, Hoffman RW.
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [Abstract] [Full Text] [Related]

  • 7. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S.
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [Abstract] [Full Text] [Related]

  • 8. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
    Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S.
    J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
    [Abstract] [Full Text] [Related]

  • 9. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE, Gonzalez-Pares EN, Rivera C.
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.
    Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963
    [Abstract] [Full Text] [Related]

  • 14. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K, Okada J, Ogiwara A, Kobayashi A, Kondo H.
    Ryumachi; 1994 Feb 15; 34(1):22-9. PubMed ID: 8146724
    [Abstract] [Full Text] [Related]

  • 15. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
    Monti M, Borgognoni F, Pastacci L, Vincentelli GM.
    G Ital Cardiol (Rome); 2016 Dec 15; 17(12):1001-1007. PubMed ID: 28151504
    [Abstract] [Full Text] [Related]

  • 16. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr 15; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

  • 17. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF, Alberca I, Tabernero MD, Cordero M, Del Pino-Montes J, Vicente V.
    J Rheumatol; 1998 Jan 15; 25(1):57-62. PubMed ID: 9458203
    [Abstract] [Full Text] [Related]

  • 18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C.
    Lupus; 2007 Jan 15; 16(10):810-6. PubMed ID: 17895304
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 2008 Sep 15; 35(9):1768-75. PubMed ID: 18634157
    [Abstract] [Full Text] [Related]

  • 20. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P, Veres K, Kiss E, Lakos G, Sonkoly I, Muszbek L, Szegedi G.
    Orv Hetil; 2000 Dec 24; 141(52):2821-5. PubMed ID: 11202118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.